Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Bacterial

Explore clinical trials studying Skin Diseases, Bacterial. Study availability and eligibility vary by location and protocol.

34 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Skin Diseases, Bacterial trial results

Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

NCT02979951

Conditions
Abscess, Bacteremia, Bacterial Infections, +46 more
Locations
  • Landeskrankenhaus Hall - Tirol Kliniken Hall in Tirol, Austria
  • A.ö. Bezirkskrankenhaus Reutte, Austria
  • AKH Wien, Universitätsklinik für Innere Medizin 1 Vienna, Austria
  • Klinikum Wels-Grieskirchen, Institut für Hygiene und Mikrobiologie Wels, Austria
View all 50 locations
View Trial Details
Enrolling by invitation

A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT07007637

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site Birmingham, Alabama, United States
  • Clinical Site North Little Rock, Arkansas, United States
  • Clinical Site Los Angeles, California, United States
  • Clinical Site Northridge, California, United States
View all 166 locations
View Trial Details
Active, not recruiting

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

NCT06993610

Conditions
Acne Vulgaris, Acneiform Eruptions, Bacterial Infections, +13 more
Locations
  • Medical Dermatology Specialists (Phoenix) Phoenix, Arizona, United States
  • First OC Dermatology Research, Inc. Irvine, California, United States
  • Wallace Medical Group, Inc. Los Angeles, California, United States
  • Northridge Clinical Trials Northridge, California, United States
View all 61 locations
View Trial Details
Active, not recruiting

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

NCT06768671

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site North Little Rock, Arkansas, United States
  • Clinical Site Stanford, California, United States
  • Clinical Site Washington D.C., District of Columbia, United States
  • Clinical Site Hollywood, Florida, United States
View all 18 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06411899

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site Los Angeles, California, United States
  • Clinical Site Northridge, California, United States
  • Clinical Site Sacramento, California, United States
  • Clinical Site San Diego, California, United States
View all 109 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06411379

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site Birmingham, Alabama, United States
  • Clinical Site North Little Rock, Arkansas, United States
  • Clinical Site Fountain Valley, California, United States
  • Clinical Site Santa Monica, California, United States
View all 106 locations
View Trial Details
Completed

Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa

NCT05322473

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Folliculitis, +13 more
Locations
  • Clinical Site Fountain Valley, California, United States
  • Clinical Site Los Angeles, California, United States
  • Clinical Site Miami, Florida, United States
  • Clinical Site Ormond Beach, Florida, United States
View all 57 locations
View Trial Details
Completed

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

NCT03747497

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +5 more
Locations
  • MicuRx Site #106 Chula Vista, California, United States
  • MicuRx Site #103 La Mesa, California, United States
  • MicuRx Site #102 Long Beach, California, United States
  • MicuRx Site #104 Stockton, California, United States
View Trial Details
Completed

Dalbavancin in Real Clinical Practice in Spain

NCT04485676

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Infections, +4 more
Locations
  • Hospital Universitario A Coruña A Coruña, Spain
  • Hospital Universitari Vall d'Hebrón Barcelona, Spain
  • Hospital Clínic Barcelona Barcelona, Spain
  • Hospital Universitario Virgen de las Nieves Granada, Spain
View Trial Details

Related conditions